Travere Therapeutics, Inc. (TVTX) Social Stream



Travere Therapeutics, Inc. (TVTX): $27.90

-0.73 (-2.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TVTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 404

in industry

Travere Therapeutics Inc (TVTX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Travere Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-15 7 $45 $20 $37 $24.67 49.98%
2021-12-16 7 $45 $20 $37.833 $24.67 53.36%
2022-01-10 7 $45 $25 $38.666 $24.67 56.73%
2022-01-25 7 $45 $27 $39 $24.67 58.09%
2022-02-01 7 $45 $27 $39.5 $24.67 60.11%
2022-02-25 7 $45 $27 $37 $24.67 49.98%
2022-02-28 7 $45 $27 $40.285 $24.67 63.3%
2022-03-10 6 $45 $27 $39.5 $24.67 60.11%

The Trend in the Analyst Price Target


TVTX's average price target has moved up $3 over the prior 42 weeks.

TVTX reports an average of 62.16% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 9 45 19 30.250 14.63 106.77%
2022-02-01 7 45 27 39.500 26.52 48.94%
2022-02-28 6 45 27 39.500 27.26 44.9%
2022-02-28 6 45 27 40.285 27.26 47.78%
2022-03-10 6 45 27 39.500 25.42 55.39%

TVTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


Over the past 16 months, TVTX's average broker recommendation rating worsened by 0.18.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Travere Therapeutics Inc fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 889.02% of that group.
  • Travere Therapeutics Inc's average analyst price target is higher than 876.79% of stocks in the small market cap category.
  • In the context of Pharmaceutical Products stocks, Travere Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 245.29% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Travere Therapeutics Inc's variance in analysts' estimates is lower than -625.54% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Travere Therapeutics Inc are TSVT, TRVN, and TRDA.

Make investment decisions regarding TVTX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.3911 seconds.